The optimal timing for non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents

被引：6

作者：

Choi, Cheol Ung ^{[1
]}

Rha, Seung-Woon ^{[1
]}

Jin, Zhe ^{[1
]}

Chen, Kang-yin ^{[1
]}

Minami, Yoshiyasu ^{[1
]}

Kim, Ji Hoon ^{[1
]}

Na, Jin Oh ^{[1
]}

Suh, Soon Yong ^{[2
]}

Kim, Jin Won ^{[1
]}

Kim, Eung Ju ^{[1
]}

Park, Chang Gyu ^{[1
]}

Seo, Hong Seog ^{[1
]}

Oh, Dong Joo ^{[1
]}

机构：

[1] Korea Univ, Guro Hosp, Ctr Cardiovasc, Seoul 152703, South Korea

[2] Konkuk Univ Hosp, Ctr Cardiovasc, Seoul, South Korea

来源：

INTERNATIONAL JOURNAL OF CARDIOLOGY | 2010年 / 139卷 / 03期

关键词：

Drug-eluting stent; Percutaneous coronary intervention; Non-cardiac surgery; ANTIPLATELET THERAPY; FOLLOW-UP; THROMBOSIS; DISCONTINUATION; IMPLANTATION;

D O I：

10.1016/j.ijcard.2008.10.050

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This study was to assess the optimal timing for non-cardiac surgery (NCS) after drug-eluting stents (DES) implantation in patients who are scheduled for NCS. In conclusions, patients undergoing early NCS within 3 months after the PCI with DES may associate with adverse outcomes. Therefore we suggest that NCS should be deferred at least 3 months after the DES implantation. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：313 / 316

页数：4

共 50 条

[1] Risk of non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents
Park, Sun-Kyung
Jung, Dhong Eun
Jung, Sung Ae
Kim, Won Ho
Bahk, Jae-Hyon
[J]. SCIENTIFIC REPORTS, 2017, 7
[2] Risk of non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents
Sun-Kyung Park
Dhong Eun Jung
Sung Ae Jung
Won Ho Kim
Jae-Hyon Bahk
[J]. Scientific Reports, 7
[3] Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents
Rabbitts, Jennifer A.
Nuttall, Gregory A.
Brown, Michael J.
Hanson, Andrew C.
Oliver, William C.
Holmes, David R.
Rihal, Charanjit S.
[J]. ANESTHESIOLOGY, 2008, 109 (04) : 596 - 604
[4] Cardiac Events After Non-Cardiac Surgery in Patients With Previous Coronary Intervention in the Drug-Eluting Stent Era
Bolad, Islam A.
Alqaqa'a, Ahmad
Khan, Bilal
Srivastav, Sudesh K.
von der Lohe, Elisabeth
Sadanandan, Saihari
Breall, Jeffrey A.
[J]. JOURNAL OF INVASIVE CARDIOLOGY, 2011, 23 (07): : 283 - 286
[5] Cardiac Risk of Noncardiac Surgery After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents
Smith, Bradford B.
Warner, Matthew A.
Warner, Nafisseh S.
Hanson, Andrew C.
Smith, Mark M.
Rihal, Charanjit S.
Gulati, Rajiv
Bell, Malcolm R.
Nuttall, Gregory A.
[J]. ANESTHESIA AND ANALGESIA, 2019, 128 (04): : 621 - 628
[6] Risk of non-cardiac surgery after coronary drug-eluting stent implantation
Compton, A.
Banerjee, S.
Adesanya, A.
Brilakis, E.
[J]. EUROPEAN HEART JOURNAL, 2006, 27 : 86 - 86
[7] Cardiology - Percutaneous coronary intervention and drug-eluting stents
Yang, YM
Moussa, I
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 172 (03) : 323 - 325
[8] Non-cardiac surgery following drug-eluting coronary stent implantation-a question of timing?
Mitchell, Andrew J.
Gillies, Michael A.
Cruden, Nicholas L.
[J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (05) : E461 - E464
[9] Non-Cardiac Surgery After Percutaneous Coronary Intervention
Sanon, Saurabh
Rihal, Charanjit S.
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (10): : 1613 - 1620
[10] Drug-Eluting Stents and Non-Cardiac Surgery: Learning Lessons the Hard Way
Nikolsky, Eugenia
Beyar, Rafael
[J]. JOURNAL OF INVASIVE CARDIOLOGY, 2011, 23 (07): : 287 - 289

← 1 2 3 4 5 →